ArticlePloS one2026
Association between laryngoplasty and pneumonia incidence in patients with unilateral vocal fold paralysis: A Japanese insurance claims database study.
Article in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveUnilateral vocal fold paralysis (UVFP) can lead to both voice impairment and dysphagia. Previous studies have suggested that surgeries aimed at improving voice function in patients with UVFP may also incidentally enhance swallowing. However, the preventive effect of such surgeries on pneumonia remains unclear. We evaluated the impact of laryngoplasty on the incidence of pneumonia in Japan using a large employment insurance claims database of corporate employees under 75 years of age and their family members.
methodsThe study cohort consisted of patients diagnosed with UVFP between January 2013 and December 2022, identified from an insurance claims database. A propensity score-matched cohort was created using a 1:3 matching ratio between the treatment and non-treatment groups. Follow-up began at the index date, defined as the initial diagnosis of UVFP, and continued until the end of the study period. The primary analysis compared the cumulative incidence of pneumonia between treatment and non-treatment groups. The secondary analysis employed a self-controlled design to compare pneumonia incidence before and after laryngoplasty within treated patients.
resultsThe full cohort included 7,641 patients with UVFP, of whom 914 comprised the matched cohort (treatment group, n = 230; non-treatment group, n = 684). The cumulative incidence of pneumonia tended to be higher in the treatment group than in the non-treatment group (hazard ratio, 1.39; 95% CI, 0.93-2.08; p = 0.098). In contrast, the self-controlled analysis demonstrated a lower pneumonia incidence after laryngoplasty compared with the pre-treatment period (incidence rate ratio, 0.36; 95% CI, 0.27-0.52; p < 0.001).
conclusionsGiven the discordant findings across analytical approaches, no definitive conclusion regarding a preventive effect can be drawn from the present study. Further studies are needed to evaluate long-term outcomes and to clarify causal relationships.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.